CA965411A - Method for the production of 2-substituted adenosine derivative - Google Patents

Method for the production of 2-substituted adenosine derivative

Info

Publication number
CA965411A
CA965411A CA130,670A CA130670A CA965411A CA 965411 A CA965411 A CA 965411A CA 130670 A CA130670 A CA 130670A CA 965411 A CA965411 A CA 965411A
Authority
CA
Canada
Prior art keywords
production
adenosine derivative
substituted adenosine
substituted
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA130,670A
Other versions
CA130670S (en
Inventor
Mikio Honjo
Ryuji Marumoto
Yoshio Yoshioka
Kin-Ichi Imai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12407770A external-priority patent/JPS5034039B1/ja
Priority claimed from DK461771AA external-priority patent/DK126043B/en
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of CA965411A publication Critical patent/CA965411A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
CA130,670A 1970-12-28 1971-12-21 Method for the production of 2-substituted adenosine derivative Expired CA965411A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12407770A JPS5034039B1 (en) 1970-12-28 1970-12-28
DK461771AA DK126043B (en) 1970-09-25 1971-09-22 Analogous process for the preparation of 2-substituted adenosine derivatives or acid addition salts thereof.
DK621371A DK135130B (en) 1970-12-28 1971-12-20 Analogous process for the preparation of 2-substituted adenosine derivatives or acid addition salts thereof.

Publications (1)

Publication Number Publication Date
CA965411A true CA965411A (en) 1975-04-01

Family

ID=27222004

Family Applications (1)

Application Number Title Priority Date Filing Date
CA130,670A Expired CA965411A (en) 1970-12-28 1971-12-21 Method for the production of 2-substituted adenosine derivative

Country Status (5)

Country Link
CA (1) CA965411A (en)
DK (1) DK135130B (en)
HU (1) HU164526B (en)
NL (1) NL7117845A (en)
SE (1) SE391337B (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180615B1 (en) 1999-06-22 2001-01-30 Cv Therapeutics, Inc. Propargyl phenyl ether A2A receptor agonists
US6214807B1 (en) 1999-06-22 2001-04-10 Cv Therapeutics, Inc. C-pyrazole 2A A receptor agonists
US6403567B1 (en) 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
US6440948B1 (en) * 1999-06-22 2002-08-27 Cv Therapeutics, Inc. Thiophene A2A receptor agonists
US7582617B2 (en) 2000-02-23 2009-09-01 Cv Therapeutics, Inc. Myocardial perfusion imaging method
US7655636B2 (en) 2004-10-20 2010-02-02 Gilead Palo Alto, Inc. Use of A2A adenosine receptor agonists
US7683037B2 (en) 2002-07-29 2010-03-23 Gilead Palo Alto, Inc. Myocardial perfusion imaging method
US7956179B2 (en) 2006-02-03 2011-06-07 Gilead Sciences, Inc. Process for preparing an A2A-adenosine receptor agonist and its polymorphs
US8133879B2 (en) 2002-07-29 2012-03-13 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
US8470801B2 (en) 2002-07-29 2013-06-25 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7183264B2 (en) * 1999-06-22 2007-02-27 Cv Therapeutics, Inc. N-pyrazole A2A receptor agonists
US7109180B2 (en) 1999-06-22 2006-09-19 Cv Therapeutics, Inc. C-pyrazole A2A receptor agonists
US6403567B1 (en) 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
US6440948B1 (en) * 1999-06-22 2002-08-27 Cv Therapeutics, Inc. Thiophene A2A receptor agonists
US6180615B1 (en) 1999-06-22 2001-01-30 Cv Therapeutics, Inc. Propargyl phenyl ether A2A receptor agonists
US6770634B1 (en) 1999-06-22 2004-08-03 Cv Therapeutics, Inc. C-pyrazole a2a receptor agonists
US6214807B1 (en) 1999-06-22 2001-04-10 Cv Therapeutics, Inc. C-pyrazole 2A A receptor agonists
US7144872B2 (en) * 1999-06-22 2006-12-05 Cv Therapeutics, Inc. N-pyrazole A2A receptor agonists
US6642210B1 (en) 1999-06-22 2003-11-04 Cv Therapeutics, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
US7553823B2 (en) 1999-06-22 2009-06-30 Cv Therapeutics, Inc. C-pyrazole A2A receptor agonists
US9045519B2 (en) 1999-06-22 2015-06-02 Gilead Sciences, Inc. N-pyrazole A2A receptor agonists
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
US7655637B2 (en) 1999-06-22 2010-02-02 Gilead Palo Alto, Inc. N-pyrazole A2A receptor agonists
US9163057B2 (en) 2000-02-23 2015-10-20 Gilead Sciences, Inc. Methods of myocardial perfusion imaging
US7582617B2 (en) 2000-02-23 2009-09-01 Cv Therapeutics, Inc. Myocardial perfusion imaging method
US8071566B2 (en) 2000-02-23 2011-12-06 Gilead Sciences, Inc. Methods of coronary imaging
US8470801B2 (en) 2002-07-29 2013-06-25 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
US7683037B2 (en) 2002-07-29 2010-03-23 Gilead Palo Alto, Inc. Myocardial perfusion imaging method
US8133879B2 (en) 2002-07-29 2012-03-13 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
US8183226B2 (en) 2002-07-29 2012-05-22 Gilead Sciences, Inc. Myocardial perfusion imaging method
US9289446B2 (en) 2002-07-29 2016-03-22 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
US8906878B2 (en) 2002-07-29 2014-12-09 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
US8106029B2 (en) 2004-10-20 2012-01-31 Gilead Sciences, Inc. Use of A2A adenosine receptor agonists
US7655636B2 (en) 2004-10-20 2010-02-02 Gilead Palo Alto, Inc. Use of A2A adenosine receptor agonists
US8524883B2 (en) 2006-02-03 2013-09-03 Gilead Sciences, Inc. Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide
US8106183B2 (en) 2006-02-03 2012-01-31 Gilead Sciences, Inc. Process for preparing an A2A-adenosine receptor agonist and its polymorphs
US7956179B2 (en) 2006-02-03 2011-06-07 Gilead Sciences, Inc. Process for preparing an A2A-adenosine receptor agonist and its polymorphs
US9085601B2 (en) 2006-02-03 2015-07-21 Gilead Sciences, Inc. Process for preparing an A2A-adenosine receptor agonist and its polymorphs
US8268988B2 (en) 2006-02-03 2012-09-18 Gilead Sciences, Inc. Process for preparing an A2A-adenosine receptor agonist and its polymorphs
USRE47301E1 (en) 2006-02-03 2019-03-19 Gilead Sciences, Inc. Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Also Published As

Publication number Publication date
NL7117845A (en) 1972-06-30
DK135130B (en) 1977-03-07
SE391337B (en) 1977-02-14
HU164526B (en) 1974-02-28
DK135130C (en) 1977-08-01

Similar Documents

Publication Publication Date Title
CA947767A (en) Process for the production of benzocyclohep thathiophenones
CA965411A (en) Method for the production of 2-substituted adenosine derivative
CA960672A (en) Process for producing quinazolinone derivatives
CA963897A (en) 2-substituted adenosine derivatives and the production thereof
AU468590B2 (en) Process for preparing 2-substituted 5-sulfamyl-benzoic acids
CA983021A (en) Method for the production of penicillanic acid derivatives
CS179373B2 (en) Method for production of pteridine derivatives.
CA942320A (en) Process for producing acetone
CA940530A (en) Process for the manufacture of quinoline derivatives
AU438472B2 (en) Quinazolinone derivatives anda process for production thereof
CA970374A (en) Process for the production of new imidazolidinone derivatives
CA925865A (en) Method for the production of triazolobenzodiazepine derivatives
CA950625A (en) Method for the production of houses
CA933919A (en) Process for the production of new 5-nitrofuryl derivatives
CA839314A (en) Method for the production of bicycloheptanedimethylols
CA964287A (en) Method for the production of isoprene
CA848462A (en) Process for the production of acylisocyanates
CA836538A (en) Process for the production of inosine
CA837099A (en) Process for 2-substituted benzimidazoles
CA925874A (en) Process for the production of new 5-nitrofuryl derivatives
AU2470071A (en) Process for the production of 1-nitroanthraquinones
CA805134A (en) Method for the production of inosine
CA842833A (en) Process for the production of new derivatives of 2-aza-adamantane
CA844620A (en) Process for the production of new nitrofuryl derivatives
CA856816A (en) Process for the production of new imidazolidinon derivatives